Prepared Statement of Dr. David Smith Deputy Director, Defense Health Agency Regarding the TRICARE Pharmacy Benefits Program before the United States Senate Armed Services Subcommittee on Personnel
Congressional Testimonies
Please note that files more than five years old may not be compliant with Section 508 of the Rehabilitation Act. If you need an accessible version of a particular file, please contact us and we will provide one for you.
Recent Congressional Testimonies
Prepared Statement of Honorable Keith Bass, Assistant Secretary of War (Health Affairs), regarding Defense Personnel Policies and Programs in Review of the Defense Authorization request for Fiscal Year 2027 and the Future Years Defense Program Before the Senate Armed Services Subcommittee on Personnel
Dr. Lester Martínez-López Assistant Secretary of Defense (Health Affairs) Regarding The Department of Defense’s Efforts to Ensure Service Members’ Access to Safe, High-Quality Pharmaceuticals
Dr. Lester Martínez-López, Assistant Secretary of Defense (Health Affairs) And Dr. Shauna Stahlman, Senior Epidemiologist, Armed Forces Health Surveillance Division Regarding Department of Defense Monitoring of COVID-19 Before The House Armed Services Committee Military Personnel Subcommittee
Dr. Lester Martínez-López, Assistant Secretary of Defense (Health Affairs), Ms. Katherine Lee, Director, Warfighter Brain Health, Captain Carlos Williams, and Director, National Intrepid Center of Excellence Regarding Traumatic Brain Injury and Blast Exposure Care [testified] Before the Senate Armed Services Committee
Honorable Gilbert R. Cisneros, Jr., Honorable Lester Martinez Lopez, Honorable Shawn Skelly, Mr. Thomas Constable, Ms. Beth Foster, regarding Fiscal Year 2024 Defense Personnel Posture [testified] before the Senate Armed Services Subcommittee on Personnel
Honorable Gilbert R. Cisneros, Under Secretary of Defense for Personnel and Readiness and Ms. Seileen Mullen, Acting Assistant Secretary of Defense for Health and Affairs testified before the House Armed Services Committee Subcommittee on Personnel on Women's Reproductive Health Issues
Ms. Seileen M. Mullen and Lt. Gen. Ronald Place discuss major activities that informed our DHA budget proposal for Fiscal Year (FY) 2023 as well as issues affecting FY 2022 execution
Honorable Gilbert Cisneros, Ms. Virginia Penrod, Dr. David Smith, Ms. Beth Foster Regarding Fiscal Year 2023 Defense Personnel Posture
Richard L. Mooney, M.D., M.P.H., Acting Deputy Assistant Secretary of Defense, Health Service Policy & Oversight Health Affairs before the Senate Armed Services Subcommittee on Personnel to address mental health needs, and access to suicide prevention resources.
Popular Congressional Testimonies
We found 290 items
Ft. Bliss Hospital Replacement
H.R. 2998, HAC Milcon for FY 2018, 115-188, Pg. 27-28
TRICARE Improper Medical Claims Payments
S. 1790, SASC Report for FY 2020, 116-48, Pg. 213-214
Modification of Requirements for Longitudinal Medical Study of Blast Pressure Exposure of Members of the Armed Forces and Collection of Exposure Information
S. 1790, NDAA Conference Report for FY 2020, 116-333, Sec. 742
Pilot Program on Display of Wait Times in Urgent Care Clinics
S. 2943, NDAA Conference and Pharmacies of Military Medical Treatment Facilities Report for FY 2017, Sec. 744(f)
Advanced Orthopedic Surgical Training
H.R. 2968, HAC Report for FY 2020, 116-84 Pg. 313-314
TRICARE Coverage of Continuous Glucose Monitors
S. 1790, SASC Report for FY 2020, 116-48, Pg. 213
Report on Service Member Discharges Related to Human Immunodeficiency Virus or Hepatitis B
H.R. 2500, HASC for FY 2020, 116-120, Pg 164-165
Terry M. Rauch, Ph.D., M.P.H., M.B.A. Acting Deputy Assistant Secretary of Defense Force Health Protection and Readiness Regarding U.S. Biodefense and Response to the Novel Coronavirus Outbreak [Testified] Before the House Committee on Oversight and Reform
Terry M. Rauch, Ph.D., M.P.H., M.B.A. Acting Deputy Assistant Secretary of Defense Force Health Protection and Readiness Regarding U.S. Biodefense and Response to the Novel Coronavirus Outbreak [Testified] Before the House Committee on Oversight and Reform
The Honorable Thomas McCaffery and Lieutenant General (Dr) Ronald Place: DHP Budget
The Honorable Thomas McCaffery Assistant Secretary of Defense (Health Affairs) and Lieutenant General (Dr) Ronald Place Director, Defense Health Agency, Regarding the Military Health System [testified] before the House Appropriations Committee Defense Subcommittee
The Honorable Thomas McCaffery Assistant Secretary of Defense and Lieutenant General Ronald Place Director Defense Health Agency Regarding the Military Health System Before the House Appropriations Committee Defense Subcommittee
The Honorable Thomas McCaffery Assistant Secretary of Defense and Lieutenant General Ronald Place Director Defense Health Agency Regarding the Military Health System Before the House Appropriations Committee Defense Subcommittee
Report on Requirement for Certain Former Members of the Armed Forces to Enroll in Medicare Part B to be Eligible for TFL; TRICARE Access Study; and Improving Health Care Choices for Severely Injured Service Members
H.R. 5515, NDAA Conference Report for FY 2019, 115-874, Sec. 734; H.R. 5515, HASC Report for FY 2019, 115-676 ,Pg. 132; S 2987, SASC Report for FY 2019, 115-262, Pg. 223
TRICARE Comprehensive Autism Care Demonstration Program FY 2020
S. 2943, SASC Report for FY 2017, 114-255, Pg. 205
Department Of Defense Health Affairs Media Roundtable Announcement of NDAA 2017, Section 703(d) Report to Congress
Thomas McCaffery, Assistant Secretary Of Defense For Health Affairs; Dr. David Smith, Reform Leader For Health Care Management; and Lieutenant General Ronald Place, Director, Defense Health Agency, participated in a Health Affairs Media Roundtable following the announcement that the NDAA 2017, Section 703(d) Report was submitted to Congress.
Pilot Program on Incentive Programs to Improve Health Care Provided Under the TRICARE Program
S. 1356, NDAA Conference Report for FY 2016, Joint Explanatory Statement Sec. 726
NDAA Section 703 Report to Congress
This report provides the Department's recommendations for changes in military treatment facilities to meet the criteria established in 10 U.S.C. § 1073d
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil View the external links disclaimer.